Airway diseases
Respiratory critical care
Sleep and breathing disorders
E-poster
Lung disease burden and management
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Methods :
Epidemiology, Cell and molecular biology, Public health, General respiratory patient care, Pulmonary function testing, Palliative care
Indoor microbial environment and asthma outcomes in childhood
A. Bédard(Paris, France)
COI
1
Asthma in elite athletes – a non-Type 2 disease
S. Rasmussen(Vejle, Denmark)
COI
2
Estimating the prevalence of undiagnosed inducible laryngeal obstruction within a severe asthma cohort
E. Akerman(Birmingham, United Kingdom)
COI
3
Exploring inflammation-related plasma biomarkers in young adults with allergic- or non-allergic asthma
S. Björkander(Stockholm, Sweden)
COI
4
Upbringing in cities is associated with an increased risk of asthma in adulthood
H. Meteran(Hvidovre, Denmark)
COI
5
The risk of depression in twin pairs discordant for asthma in a nationwide study
H. Meteran(Hvidovre, Denmark)
COI
6
LSC - 2021 - Associations between pediatric asthma and adult lung diseases
N. Juber(Jakarta, Indonesia)
COI
7
Late Breaking Abstract - Shared genetic origins of obesity and poor ICS response in children with asthma
C. Longo(Laval, Canada)
COI
8
Prevalence and severity of multidimensional breathlessness among elderly men in the population.
M. Olsson(Helsingborg, Sweden)
COI
9
Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
L. Oostrik('s-Gravenhage, Netherlands)
COI
10
Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease
A. Jordan(Copenhagen N, Denmark)
COI
11
Severe a1-antitrypsin deficiency associated with reduced blood pressure and lower plasma triglycerides in the general population
S. Voss Winther(København S, Denmark)
COI
12
COPD - Impact on Mortality in Locals with and without Specific Medication
T. Nery(São Paulo (SP), Brazil)
COI
13
Prevalence of chronic obstructive pulmonary diseases with acute exacerbation and its associated factors treated by out-of-hospital emergencies in Madrid
A. CINTORA(Alcobendas, Spain)
COI
14
Comorbidity of adult asthma and gastroesophageal reflux disease in a large twin cohort: the role of genes and affective traits.
B. Brew Haasdyk(Sydney (NSW), Australia)
COI
15
Overview of hospital care of elderly patients with coronavirus infection in COVID unit in Slovenia.
J. Regvat(Hoče, Slovenia)
COI
16
Late Breaking Abstract - COVID-19 Infodemic and Health-Related Quality of Life (HRQoL) in Patients with Chronic Respiratory Diseases (CRDs)
S. Moitra(Edmonton, Canada)
COI
17
Late Breaking Abstract - Severe Asthma Prevalence, Care Pathways, and Health Care Resource Utilization in France
A. Bourdin(Montpellier Cedex 5, France)
COI
18
Late Breaking Abstract - Oral corticosteroid (OCS) risk predictor for osteoporosis
B. Stanley(One Shenton, Singapore)
COI
19
. . .
